Array
(
[id] => 17928456
[patent_doc_number] => 20220323581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => Materials And Methods Of Treating MHC-1-Opathy Risk Haplotypes
[patent_app_type] => utility
[patent_app_number] => 17/714717
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714717 | Materials And Methods Of Treating MHC-1-Opathy Risk Haplotypes | Apr 5, 2022 | Pending |